Core Scientific, Inc./tx Income Statement
CORZ / Financials|6 years of annual SEC 10-K data (FY2020-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Core Scientific, Inc./tx reported $319M in revenue and $289M in net loss for FY2025. Revenue has grown at a 39.5% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $319.0M | $510.7M | $502.4M | $640.3M | $544.5M | $60.3M |
| Cost of Revenue | $281.1M | $389.6M | $378.9M | $631.9M | $305.6M | $50.9M |
| Gross Profit | $37.9M | $121.1M | $123.5M | $8.4M | $238.9M | $9.4M |
| SG&A Expense | $159.2M | $113.7M | $108.1M | $213.3M | $60.5M | $14.6M |
| R&D Expense | - | $11.8M | $7.2M | $27.0M | $7.7M | $5.3M |
| Operating Income | -$245.6M | -$142.1M | $9.0M | -$2.1B | $131.5M | -$6.3M |
| Income Tax | $583.0K | $859.0K | $683.0K | -$17.1M | $15.8M | $0 |
| Net Income | -$288.6M | -$1.4B | -$246.5M | -$2.1B | $47.3M | -$12.2M |
| EPS (Basic) | -$0.65 | -$6.30 | $0.23 | -$0.14 | $0.23 | -$0.14 |
| EPS (Diluted) | -$0.65 | -$6.30 | $0.20 | -$0.14 | $0.20 | -$0.14 |
| Shares Outstanding | 292.6M | 386.9M | 375.2M | 271.6M | 233.3M | 157.6M |
| Gross Margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% |
| Operating Margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% | -10.5% |
| Profit Margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |